Abstract
United States Wound Care Management Investment Opportunities, Analysis and
Forecasts to 2012
Summary
This report is an essential source for in-depth information and data relating
to United States wound care management market. It also offers detailed and
comprehensive coverage of market revenue, volume, distribution and company
share information; and latest news, financial deals and pipeline products
information of each of the key sub-segments of the wound care management in
United States
Scope
・ The report provides wound care management information broken down into
detailed categories and segments in United States.
・ Total revenues,
products sold, end users, and average pricing.
・ Market shares of all the
key competitors.
・ Key pipeline products that are set to shape the
market, broken down by sector.
・ Information on the top medical equipment
companies in the sector in the country covering business description,
strategic analysis, and financial information.
・ Healthcare structure,
regulatory environment, approval process, pricing trends and
reimbursement.
・ Product and brand updates, strategy changes, R&D
projects, corporate expansions and contractions and regulatory changes.
・
Key mergers and acquisitions, partnerships, private equity investments and
IPOs.
・ Customer, hospitals and physicians data.
Reasons to buy
・ Gain a strong understanding of the wound care management market in United
States.
・ Evaluate and compare the attractiveness of the market in the
country.
・ Identify growth segments and opportunities in each industry
sector within the country.
・ Evaluate the pipeline of key products that
will change the sector, and identify threats and opportunities before the
products are launched in the country.
・ Analyze the competitiveness of the
market in the country and identify hotspots.
・ Develop strategies based
on the latest product, brand, expansion and research and development news in
the country.
・ Do deals with an understanding of how competitors are
financed, and the mergers and partnerships that have shaped the market in the
country.
・ Identify and analyze the strengths and weaknesses of the
industry incumbents in the country.
Table of Contents
1 Table of Contents 2
1.1 List of Tables 6
1.2 List of Figures 10
2 Introduction 13
2.1 What Is This Report About? 13
2.2 Definitions
13
3 Healthcare Sector Review 15
3.1 Healthcare Expenditure 15
3.2
Healthcare Infrastructure 20
4 Wound Care Mangement in United States
27
4.1 Wound Care Management Overall Revenues (2000-2012) 27
4.2 Wound
Care Management Overall Volume (2000-2012) 33
4.3 Wound Care Management
Overall Company Shares (2005-2006) 36
5 Wound Closure Devices in United
States 37
5.1 Wound Closure Devices Overall Revenues (2000-2012) 37
5.2 Wound Closure Devices Overall Volume (2000-2012) 47
5.3 Wound Closure
Devices Average Price (2000-2012) 55
5.4 Wound Closure Devices
Distribution Share 61
5.5 Wound Closure Devices Company Share 62
6
Ostomy in United States 63
6.1 Ostomy Overall revenues (2000-2012) 63
6.2 Ostomy Category Overall Volume (2000-2012) 65
6.3 Ostomy Average Price
(2000-2012) 67
6.4 Ostomy Distribution Share (2005-2006) 69
6.5 Ostomy
Company Share (2005-2006) 70
7 Advanced Wound Management in United States
71
7.1 Advanced Wound Management Revenue (2000-2012) 71
7.2 Advanced
Wound Management Overall Volume (2000-2012) 73
7.3 Advanced Wound
Management Average Price (2000-2012) 75
7.4 Advanced Wound Management
Distribution Share (2005-2006) 77
7.5 Advanced Wound Management Company
Share (2005-2006) 78
8 Traditional Wound Management in United States
79
8.1 Traditional Wound Management Overall Revenue (2000-2012) 79
8.2
Traditional Wound Management Overall Volume (2000-2012) 81
8.3 Traditional
Wound Management Average Price (2000-2012) 83
8.4 Traditional Wound
Management Distribution Share (2005-2006) 85
8.5 Traditional Wound
Management Company Share (2005-2006) 86
9 Compression Therapy in United
States 87
9.1 Compression Therapy Category Revenue (2000-2012) 87
9.2
Compression Therapy Category Volume (2000-2012) 89
9.3 Compression Therapy
Average Price (2000-2012) 91
9.4 Compression Therapy Distribution Share
(2005-2006) 93
9.5 Compression Therapy Company Share (2005-2006) 94
10
Baxter International Company Profile 95
10.1 Company Overview 95
10.2
Business Overview 95
10.3 Value Chain Analysis 100
10.4 SWOT Analysis
102
10.5 Financial and Operational Review 105
10.6 Locations And
Subsidiaries 106
10.7 Baxter International Inc. Pipeline Products 108
11 Covidien Ltd./Tyco Healthcare Company Profile 109
11.1 Company Overview
109
11.2 Business Overview 109
11.3 Value Chain Analysis 113
11.4
SWOT Analysis 115
11.5 Financial and Operational Review 119
11.6
Locations And Subsidiaries 121
11.7 Covidien Ltd./Tyco Healthcare Pipeline
Products 122
12 3M Company Profile 125
12.1 Company Overview 125
12.2 Business Overview 125
12.3 Value Chain Analysis 130
12.4 SWOT
Analysis 132
12.5 Financial and Operational Review 135
12.6 Locations
And Subsidiaries 136
13 Ethicon, Inc. Company Profile 138
13.1 Company
Overview 138
13.2 Business Overview 138
13.3 Locations And
Subsidiaries 139
14 Smith & Nephew Plc Company Profile 141
14.1
Company Overview 141
14.2 Business Overview 141
14.3 Value Chain
Analysis 148
14.4 SWOT Analysis 150
14.5 Financial and Operational
Review 153
14.6 Locations And Subsidiaries 154
14.7 Smith & Nephew Plc
Pipeline Products 156
15 Regulation System 157
15.1 Medical Equipment
Approval Process 157
16 Pricing and Reimbursement 164
16.1 Government
Policies 164
16.2 Private Insurance 165
16.3 Diagnosis Related Groups
(DRG) 166
17 Distribution Structure 167
17.1 Distribution Structure
167
18 Financial Deals Landscape 168
18.1 Acquisition 168
18.2
Private Equity 175
18.3 Venture Financing 180
18.4 IPO 188
18.5
Debt Offerings 194
18.6 Partnership 199
18.7 Asset Transactions
213
19 Recent Developments 216
19.1 Corporate Communications 216
19.2 Legal and Regulatory 217
19.3 Other Significant Developments 217
20 Appendix 219
20.1 Methodology 219
20.2 Currency Conversion 220
20.3 Contact Us 221
20.4 Disclaimer 221
1.1 List of Tables
Table 1: United States Healthcare Expenditure, 2003-2010 19
Table 2:
United States Healthcare Expenditure by Age (per person), 2000-2003 20
Table 3: United States Healthcare Expenditure by Sex (per person), 2000-2003
20
Table 4: United States Healthcare Expenditure by Race (per person),
2000-2003 21
Table 5: United States Personal Healthcare Expenditure by
Type, 2000-2004 21
Table 6: United States Personal Healthcare Expenditure
by Source, 2000-2004 22
Table 7: Total Number of Doctors in the United
States, 2003-2010 25
Table 8: Number of Doctors by Specialty in the United
States, 2003-2010 26
Table 9: Doctors by Region (Number per 10,000
Civilian Population), 2002-2004 27
Table 10: Doctors by Region (Number per
10,000 Civilian Population), 2002-2004 (Cont.) 28
Table 11: Total
Hospitals in the United States, 2000-2004 28
Table 12: Community Hospitals
by Number of Beds in the United States, 2000-2004 29
Table 13: Number of
Hospital Beds in the United States, 2000-2004 29
Table 14: Number of
Hospital Beds by Range in the United States, 2000-2004 29
Table 15: Wound
Care Management, United States, Overall Revenues ($ mn), 2000-2012 30
Table 16: Wound Care Management, United States, Overall Revenues ($ mn),
Historic, 2000-2007 31
Table 17: Wound Care Management, United States,
Overall Revenues ($ mn), Forecast, 2007-2012 32
Table 18: Wound Care
Management, United States, Category Revenues ($ mn), 2000-2012 33
Table
19: Wound Care Management, United States, Category Revenues ($ mn), Historic,
2000-2007 34
Table 20: Wound Care Management, United States, Category
Revenues ($ mn), Forecast, 2007-2012 35
Table 21: Wound Care Management,
United States, Category Volume (Units), 2000-2012 36
Table 22: Wound Care
Management, United States, Category Volume (Units), Historic, 2000-2007 37
Table 23: Wound Care Management, United States, Category Volume (Units),
Forecast, 2007-2012 38
Table 24: Wound Care Management, United States,
Overall Company Share by Revenue ($ mn), 2005-2006 39
Table 25: Wound
Closure Devices, United States, Overall Revenues ($ mn), Historic, 2000-2007
40
Table 26: Wound Closure Devices, United States, Overall Revenues ($
mn), Forecast, 2007-2012 41
Table 27: Wound Closure Devices, United
States, Revenue by Segment ($ mn), Historic, 2000-2007 42
Table 28: Wound
Closure Devices, United States, Revenue by Segment ($ mn), Forecast, 2007-2012
43
Table 29: Skin Closure Devices, United States, Overall Revenues ($ mn),
Historic, 2000-2007 44
Table 30: Skin Closure Devices, United States,
Overall Revenues ($ mn), Forecast, 2007-2012 45
Table 31: Hemostats,
United States, Overall Revenues ($ mn), Historic, 2000-2007 46
Table 32:
Hemostats, United States, Overall Revenues ($ mn), Forecast, 2007-2012 47
Table 33: Tissue Sealants, United States, Overall Revenues ($ mn), Historic,
2000-2007 48
Table 34: Tissue Sealants, United States, Overall Revenues ($
mn), Forecast, 2007-2012 49
Table 35: Wound Closure Devices, United
States, Overall Volume (Units), Historic, 2000-2007 50
Table 36: Wound
Closure Devices, United States, Overall Volume (Units), Forecast, 2007-2012
51
Table 37: Skin Closure Devices, United States, Overall Volume (Units),
Historic, 2000-2007 52
Table 38: Skin Closure Devices, United States,
Overall Volume (Units), Forecast, 2007-2012 53
Table 39: Hemostats, United
States, Overall Volume (Units), Historic, 2000-2007 54
Table 40:
Hemostats, United States, Overall Volume (Units), Forecast, 2007-2012 55
Table 41: Tissue Sealants, United States, Overall Volume (Units), Historic,
2000-2007 56
Table 42: Tissue Sealants, United States, Overall Volume
(Units), Forecast, 2007-2012 57
Table 43: Hemostats, United States,
Average Price ($), Historic, 2000-2007 58
Table 44: Hemostats, United
States, Average Price ($), Forecast, 2007-2012 59
Table 45: Tissue
Sealants, United States, Average Price ($), Historic, 2000-2007 60
Table
46: Tissue Sealants, United States, Average Price ($), Forecast, 2007-2012
61
Table 47: Skin Closure Devices, United States, Average Price ($),
Historic, 2000-2007 62
Table 48: Skin Closure Devices, United States,
Average Price ($), Forecast, 2007-2012 63
Table 49: Wound Closure Devices,
United States, Distribution Share by Revenue ($ mn), 2005-2006 64
Table
50: Wound Closure Devices, United States, Company Share by Revenue ($ mn),
2005-2006 65
Table 51: Ostomy, United States, Overall Revenues ($ mn),
Historic, 2000-2007 66
Table 52: Ostomy, United States, Overall Revenues
($ mn), Forecast, 2007-2012 67
Table 53: Ostomy, United States, Overall
Volume (Units), Historic, 2000-2007 68
Table 54: Ostomy, United States,
Overall Volume (Units), Forecast, 2007-2012 69
Table 55: Ostomy, United
States, Average Price ($), Historic, 2000-2007 70
Table 56: Ostomy, United
States, Average Price ($), Forecast, 2007-2012 71
Table 57: Ostomy, United
States, Distribution Share by Revenue ($ mn), 2005-2006 72
Table 58:
Ostomy, United States, Company Share by Revenue ($ mn), 2005-2006 73
Table
59: Advanced Wound Management, United States, Overall Revenues ($ mn),
Historic, 2000-2007 74
Table 60: Advanced Wound Management, United States,
Overall Revenues ($ mn), Forecast, 2007-2012 75
Table 61: Advanced Wound
Management, United States, Overall Volume (Units), Historic, 2000-2007 76
Table 62: Advanced Wound Management, United States, Overall Volume (Units),
Forecast, 2007-2012 77
Table 63: Advanced Wound Management, United States,
Average Price ($), Historic, 2000-2007 78
Table 64: Advanced Wound
Management, United States, Average Price ($), Forecast, 2007-2012 79
Table
65: Advanced Wound Management, United States, Distribution Share by Revenue ($
mn), 2005-2006 80
Table 66: Advanced Wound Management, United States,
Company Share by Revenue ($ mn), 2005-2006 81
Table 67: Traditional Wound
Management, United States, Overall Revenues ($ mn), Historic, 2000-2007 82
Table 68: Traditional Wound Management, United States, Overall Revenues ($
mn), Forecast, 2007-2012 83
Table 69: Traditional Wound Management, United
States, Overall Volume (Units), Historic, 2000-2007 84
Table 70:
Traditional Wound Management, United States, Overall Volume (Units), Forecast,
2007-2012 85
Table 71: Traditional Wound Management, United States,
Average Price ($), Historic, 2000-2007 86
Table 72: Traditional Wound
Management, United States, Average Price ($), Forecast, 2007-2012 87
Table
73: Traditional Wound Management, United States, Distribution Share by Revenue
($ mn), 2005-2006 88
Table 74: Traditional Wound Management, United
States, Company Share by Revenue ($ mn), 2005-2006 89
Table 75:
Compression Therapy, United States, Overall Revenues ($ mn), Historic,
2000-2007 90
Table 76: Compression Therapy, United States, Overall
Revenues ($ mn), Forecast, 2007-2012 91
Table 77: Compression Therapy,
United States, Overall Volume (Units), Historic, 2000-2007 92
Table 78:
Compression Therapy, United States, Overall Volume (Units), Forecast,
2007-2012 93
Table 79: Compression Therapy, United States, Average Price
($), Historic, 2000-2007 94
Table 80: Compression Therapy, United States,
Average Price ($), Forecast, 2007-2012 95
Table 81: Compression Therapy,
Distribution Share by Revenue ($ mn), 2005-2006 96
Table 82: Compression
Therapy, United States, Company Share by Revenue ($ mn), 2005-2006 97
Table 83: Baxter International Inc., SWOT Analysis, 2006 105
Table
84: Baxter International Inc., Financial Statements, USD Million,
2002-2006 108
Table 85: Baxter International Inc., Financial Ratios,
USD Million, 2002-2006 109
Table 86: Baxter International Inc., Other
Locations 110
Table 87: Baxter International Inc., Subsidiaries
110
Table 88: Covidien Ltd./Tyco Healthcare, SWOT Analysis, 2007
119
Table 89: Covidien Ltd./Tyco Healthcare, Financial Statements,
USD Million, 2003-2007 122
Table 90: Covidien Ltd./Tyco Healthcare,
Financial Ratios, USD Million, 2003-2007 123
Table 91: Covidien
Ltd./Tyco Healthcare, Other Locations 124
Table 92: Covidien
Ltd./Tyco Healthcare, Subsidiaries 124
Table 93: 3M Company, SWOT
Analysis, 2006 135
Table 94: 3M Company, Financial Statements, USD
Million, 2002-2006 138
Table 95: 3M Company, Financial and
Operational Overview, USD Million, 2002-2006 139
Table 96: 3M
Company, Subsidiaries 140
Table 97: Ethicon, Inc., Other Locations
143
Table 98: Ethicon, Inc., Subsidiaries 143
Table 99:
Smith & Nephew Plc, SWOT Analysis, 2006 153
Table 100: Smith & Nephew
Plc, Financial Statements, USD Million, 2002-2006 156
Table 101:
Smith & Nephew Plc, Financial Ratios, USD Million, 2002-2006 157
Table
102: Smith & Nephew Plc, Other Locations 158
Table 103: Medical
Equipment Registration Fee in United States, 2007 166
Table 104: Medical
Device Approval Time in United States, 2004 166
Table 105: Currency
Conversion from USD to Local Currency at 2007 Constant Rate 223
1.2
List of Figures
Figure 1: United States, Healthcare Expenditure by Source,
2003 19
Figure 2: United States, Healthcare Infrastructure, Top Level
View, 2007 24
Figure 3: Healthcare Expenses Segmentation by End User, 2003
25
Figure 4: Wound Care Management, United States, Overall Revenues ($
mn), 2000-2012 30
Figure 5: Wound Care Management, United States, Overall
Revenues ($ mn), Historic, 2000-2007 31
Figure 6: Wound Care Management,
United States, Overall Revenues ($ mn), Forecast, 2007-2012 32
Figure 7:
Wound Care Management, United States, Category Revenues ($ mn), 2000-2012
33
Figure 8: Wound Care Management, United States, Category Revenues ($
mn), Historic, 2000-2007 34
Figure 9: Wound Care Management, United
States, Category Revenues ($ mn), Forecast, 2007-2012 35
Figure 10: Wound
Care Management, United States, Category Volume (Units), 2000-2012 36
Figure 11: Wound Care Management, United States, Category Volume (Units),
Historic, 2000-2007 37
Figure 12: Wound Care Management, United States,
Category Volume (Units), Forecast, 2007-2012 38
Figure 13: Wound Care
Management, United States, Overall Company Share (%), 2006 39
Figure 14:
Wound Closure Devices, United States, Overall Revenues ($ mn), Historic,
2000-2007 40
Figure 15: Wound Closure Devices, United States, Overall
Revenues ($ mn), Forecast, 2007-2012 41
Figure 16: Wound Closure Devices,
United States, Revenue by Segment ($ mn), Historic, 2000-2007 42
Figure
17: Wound Closure Devices, United States, Revenue by Segment ($ mn), Forecast,
2007-2012 43
Figure 18: Skin Closure Devices, United States, Overall
Revenues ($ mn), Historic, 2000-2007 44
Figure 19: Skin Closure Devices,
United States, Overall Revenues ($ mn), Forecast, 2007-2012 45
Figure 20:
Hemostats, United States, Overall Revenues ($ mn), Historic, 2000-2007 46
Figure 21: Hemostats, United States, Overall Revenues ($ mn), Forecast,
2007-2012 47
Figure 22: Tissue Sealants, United States, Overall Revenues
($ mn), Historic, 2000-2007 48
Figure 23: Tissue Sealants, United States,
Overall Revenues ($ mn), Forecast, 2007-2012 49
Figure 24: Wound Closure
Devices, United States, Overall Volume (Units), Historic, 2000-2007 50
Figure 25: Wound Closure Devices, United States, Overall Volume (Units),
Forecast, 2007-2012 51
Figure 26: Skin Closure Devices, United States,
Overall Volume (Units), Historic, 2000-2007 52
Figure 27: Skin Closure
Devices, United States, Overall Volume (Units), Forecast, 2007-2012 53
Figure 28: Hemostats, United States, Overall Volume (Units), Historic,
2000-2007 54
Figure 29: Hemostats, United States, Overall Volume (Units),
Forecast, 2007-2012 55
Figure 30: Tissue Sealants, United States, Overall
Volume (Units), Historic, 2000-2007 56
Figure 31: Tissue Sealants, United
States, Overall Volume (Units), Forecast, 2007-2012 57
Figure 32:
Hemostats, United States, Average Price ($), Historic, 2000-2007 58
Figure
33: Hemostats, United States, Average Price ($), Forecast, 2007-2012 59
Figure 34: Tissue Sealants, United States, Average Price ($), Historic,
2000-2007 60
Figure 35: Tissue Sealants, United States, Average Price ($),
Forecast, 2007-2012 61
Figure 36: Skin Closure Devices, United States,
Average Price ($), Historic, 2000-2007 62
Figure 37: Skin Closure Devices,
United States, Average Price ($), Forecast, 2007-2012 63
Figure 38: Wound
Closure Devices, United States, Distribution Share (%), 2006 64
Figure 39:
Wound Closure Devices, United States, Company Share (%), 2006 65
Figure
40: Ostomy, United States, Overall Revenues ($ mn), Historic, 2000-2007 66
Figure 41: Ostomy, United States, Overall Revenues ($ mn), Forecast, 2007-2012
67
Figure 42: Ostomy, United States, Overall Volume (Units), Historic,
2000-2007 68
Figure 43: Ostomy, United States, Overall Volume (Units),
Forecast, 2007-2012 69
Figure 44: Ostomy, United States, Average Price
($), Historic, 2000-2007 70
Figure 45: Ostomy, United States, Average
Price ($), Forecast, 2007-2012 71
Figure 46: Ostomy, United States,
Company Share (%), 2006 73
Figure 47: Advanced Wound Management, United
States, Overall Revenues ($ mn), Historic, 2000-2007 74
Figure 48:
Advanced Wound Management, United States, Overall Revenues ($ mn), Forecast,
2007-2012 75
Figure 49: Advanced Wound Management, United States, Overall
Volume (Units), Historic, 2000-2007 76
Figure 50: Advanced Wound
Management, United States, Overall Volume (Units), Forecast, 2007-2012 77
Figure 51: Advanced Wound Management, United States, Average Price ($),
Historic, 2000-2007 78
Figure 52: Advanced Wound Management, United
States, Average Price ($), Forecast, 2007-2012 79
Figure 53: Advanced
Wound Management, United States, Distribution Share (%), 2006 80
Figure
54: Advanced Wound Management, United States, Company Share (%), 2006 81
Figure 55: Traditional Wound Management, United States, Overall Revenues ($
mn), Historic, 2000-2007 82
Figure 56: Traditional Wound Management,
United States, Overall Revenues ($ mn), Forecast, 2007-2012 83
Figure 57:
Traditional Wound Management, United States, Overall Volume (Units), Historic,
2000-2007 84
Figure 58: Traditional Wound Management, United States,
Overall Volume (Units), Forecast, 2007-2012 85
Figure 59: Traditional
Wound Management, United States, Average Price ($), Historic, 2000-2007 86
Figure 60: Traditional Wound Management, United States, Average Price ($),
Forecast, 2007-2012 87
Figure 61: Traditional Wound Management, United
States, Distribution Share (%), 2006 88
Figure 62: Traditional Wound
Management, United States, Company Share (%), 2006 89
Figure 63:
Compression Therapy, United States, Overall Revenues ($ mn), Historic,
2000-2007 90
Figure 64: Compression Therapy, United States, Overall
Revenues ($ mn), Forecast, 2007-2012 91
Figure 65: Compression Therapy,
United States, Overall Volume (Units), Historic, 2000-2007 92
Figure 66:
Compression Therapy, United States, Overall Volume (Units), Forecast,
2007-2012 93
Figure 67: Compression Therapy, United States, Average Price
($), Historic, 2000-2007 94
Figure 68: Compression Therapy, United States,
Average Price ($), Forecast, 2007-2012 95
Figure 69: Compression Therapy,
Distribution Share (%), 2006 96
Figure 70: Compression Therapy, United
States, Company Share (%), 2006 97
Figure 71: Baxter International
Inc., Value Chain Analysis 103
Figure 72: Covidien Ltd./Tyco
Healthcare, Value Chain Analysis 116
Figure 73: 3M Company, Value
Chain Analysis 133
Figure 74: Smith & Nephew Plc, Value Chain
Analysis 151
Figure 75: Medical Equipment Approval Process in the United
States, 2007 161
Figure 76: PMA Approval Process in the United States,
2007 163
Figure 77: The 510(k) Approval Process for Medical Devices in the
United States, 2007 164
Figure 78: Reimbursement Structure in the United
States, 2007 169
Figure 79: Distribution Structure of Medical Equipment in
the United States, 2006 170
|
相關報告
|
